NASDAQ: ANEB - Anebulo Pharmaceuticals, Inc.

Yield per half year: -31.73%
Sector: Healthcare

Current price
2.6 $
Average price
1.57 $ -39.54%
Price based on EPS
1.85 $ -28.74%
Discount price Net Income
1.29 $ -50.33%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 1.85 $
Current price = 2.6 $ (difference = -28.74%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -7.46 $
Current price = 2.6 $ (difference = -386.74%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -8.29 $
Current price = 2.6 $ (difference = -418.8%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe